Architecture of Vanadium‐Based MXene Dysregulating Tumor Redox Homeostasis for Amplified Nanozyme Catalytic/Photothermal Therapy
Advanced Materials · 2024
DOI: 10.1002/adma.202307115 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Materials, 2024. Verfasst von Ruoxi Zhao und 9 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Superlight Materials and Surface Technology, Ministry of Education, College of Materials Science and Chemical Engineering, Harbin E…. Hauptthemen laut MEDLINE: Photothermal Therapy, Neoplasms, Nitrites, Transition Elements. Die Arbeit wurde bisher 110-mal zitiert (Crossref) und nennt 74 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Heilongjiang Natural Science Foundation project of Outstanding youth project, Natural Science Foundation of Shandong Province.
Abstract (Originalsprache)
Taking the significance of the special microenvironment for tumor cell survival into account, disrupting tumor redox homeostasis is highly prospective for improving therapeutic efficacy. Herein, a multifunctional 2D vanadium‐based MXene nanoplatform, V 4 C 3 /atovaquone@bovine albumin (V 4 C 3 /ATO@BSA, abbreviated as VAB) has been elaborately constructed for ATO‐enhanced nanozyme catalytic/photothermal therapy. The redox homeostasis within the tumor cells is eventually disrupted, showing a remarkable anti‐tumor effect. The VAB nanoplatform with mixed vanadium valence states can induce a cascade of catalyzed reactions in the tumor microenvironment, generating plenty of reactive oxygen species (ROS) with effective glutathione consumption to amplify oxidative stress. Meanwhile, the stable and strong photothermal effect of VAB under near‐infrared irradiation not only causes the necrosis of tumor cells, but also improves its peroxidase‐like activity. In addition, the release of ATO can effectively alleviate endogenous oxygen consumption to limit triphosadenine formation and inhibit mitochondrial respiration. As a result, the expression of heat shock proteins is effectively suppressed to overcome thermoresistance and the production of ROS can be further promoted due to mitochondrial injury. Moreover, VAB also presents high photoacoustic and photothermal imaging performances. In brief, the multifunctional nanoplatform can provide ATO‐enhanced nanozyme catalytic/photothermal therapy with broadening the biomedical applications of vanadium‐based MXene.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Key Laboratory of Superlight Materials and Surface Technology, Ministry of Education, College of Materials Science and Chemical Engineering, Harbin Engineering University, Harbin, 150001, P. R. China.
- Cancer Institute, Affiliated Tumor Hospital of Nantong University, Nantong, 226631, P. R. China.
- Department of Ultrasound, The First Affiliated Hospital of Harbin Medical University, Harbin, 150001, P. R. China.
ORCID-Profile: Ruoxi Zhao, Yanlin Zhu, Lili Feng, Shili Gai, Piaoping Yang
Förderung
- National Natural Science Foundation of China
- Heilongjiang Natural Science Foundation project of Outstanding youth project
- Natural Science Foundation of Shandong Province
- China Postdoctoral Science Foundation
- Fundamental Research Funds for the Central Universities
Zitieren
APA
Zhao, R., Zhu, Y., Feng, L., Liu, B., Hu, Y., Zhu, H., Zhao, Z., Ding, H., Gai, S., & Yang, P. (2024). Architecture of Vanadium‐Based MXene Dysregulating Tumor Redox Homeostasis for Amplified Nanozyme Catalytic/Photothermal Therapy. Advanced Materials. https://doi.org/10.1002/adma.202307115
Vancouver
Zhao R, Zhu Y, Feng L, Liu B, Hu Y, Zhu H, et al. Architecture of Vanadium‐Based MXene Dysregulating Tumor Redox Homeostasis for Amplified Nanozyme Catalytic/Photothermal Therapy. Advanced Materials. 2024. doi:10.1002/adma.202307115
BibTeX
@article{Zhao2024,
author = {Zhao, Ruoxi and Zhu, Yanlin and Feng, Lili and Liu, Bin and Hu, Yaoyu and Zhu, Haixia and Zhao, Zhiyu and Ding, He and Gai, Shili and Yang, Piaoping},
title = {Architecture of Vanadium‐Based MXene Dysregulating Tumor Redox Homeostasis for Amplified Nanozyme Catalytic/Photothermal Therapy},
journal = {Advanced Materials},
year = {2024},
doi = {10.1002/adma.202307115}
}
EUVIMED